Allied Market Research
Loading...
Cart
0

Thyroid Gland Disorder Treatment Market Expected to Reach $2,771 Million,Globally,by 2025

 

Report Code : A03420

quote The initiative undertaken by organizations and companies to spread awareness in regards with thyroid conditions and availability of large number of undiagnosed patients are the major driving factors that are projected to boost the market growth. quote

Garima Chandra
Senior Research Analyst, Healthcare at AMR

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, Thyroid Gland Disorder Treatment Market by Drug Type, Route of Administration, Distribution/Sales Channel, and Disease Type: Global Opportunity Analysis and Industry Forecast, 20172025," the global thyroid gland disorder market was valued at $2,057 million in 2017, and is estimated to reach $2,771 million at a CAGR of 3.8% from 2018 to 2025. North America was the highest contributor to the thyroid gland disorder treatment market in 2017; however, Asia-Pacific is expected to witness the highest growth during the forecast period.

The thyroid gland produces hormones, which regulates the body metabolism. The abnormal release of thyroid hormones causes thyroid disorder. Thyroid hormone is necessary to regulate the heart rate, blood pressure, and body temperature. However, due to factors such as iodine deficiency, autoimmunity, and congenital hypothyroidism, one-third of the population is at the risk of having thyroid disease.

The major factors that drive the growth of the thyroid gland disorder market include increase in incidence of thyroid gland disorders, development of effective combination thyroid disorders drug therapies, and increase in number of disease awareness programs in developing regions. However, side effects of the medication and stringent government regulations limit the market growth. Conversely, availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders in the emerging economies are anticipated to provide numerous opportunities for the market growth during the forecast period.

Among the disease type, the hypothyroidism segment occupied the largest share, and is anticipated to continue its dominance during the forecast period, owing to the high prevalence of iodine deficiency population worldwide, and is the most commonly occurring thyroid disorder.

Among the distribution channel, the wholesaler or distributor segment occupied the largest share. However, mail-order pharmacy is the fastest growing segment as these services help customers save money and convenience. Among the route of administration, the oral segment occupied the largest share as most of the medications available in the market are in the form of tablets or pills that can easily be administered by the patients.

Based on region, North America occupied the largest share in 2017 owing to the highest prevalence rate for thyroid disorders, large number of diagnosed patients as compared to other regions, and well-established healthcare infrastructure. However, Asia-Pacific is expected to grow at the highest CAGR of 4.4% during the study period, due to increase in number of thyroid disease awareness programs in the developing regions and availability of large number of undiagnosed thyroid gland disorder patients.

Key Findings Of The Thyroid Gland Disorder Treatment Market :

  • The Liothyronine segment is projected to grow at the highest rate among the drug type segment during the analysis period.
  • North America dominated global thyroid gland disorder treatment market in 2017, and is projected to continue its dominance in future.
  • China is expected to grow at the highest rate in Asia-Pacific during the forecast period.
  • Wholesaler/distributor is the largest contributor among the distribution channels segments in 2017.
  • The hypothyroidism segment generated the highest revenue, and is expected to continue its dominance in future.

The key players operating in the global thyroid gland disorder treatment market include AbbVie Inc., Pfizer Inc., Merck & Co., Inc., Lannett Company, Inc., Allergan plc, Mylan N.V., GlaxoSmithKline plc, Novartis AG, RLC LABS, Inc., and Abbott Laboratories. Other prominent players in the value chain include Takeda Pharmaceutical Company Limited, Aspen, Amgen Inc., Endo International plc, Acella Pharmaceuticals, LLC, and Gemini Laboratories, LLC.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Ram D
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote Thyroid Gland Disorder Treatment Market by Disease Type (Hyperthyroidism and Hypothyroidism), Drug Type (Levothyroxine, Liothyronine, Propylthiouracil, Imidazole-based Compound, and Others), Route of Administration (Oral, Intravenous, and Others), and Distribution/Sales Channel (Wholesaler/Distributor, Retailer, Mail-order Pharmacy, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025 quote

View Report
 
 
Avenue Video Loading...

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"Thyroid Gland Disorder Treatment Market"
Purchase Enquiry